Stock Events

Stock Events

Search...

Galmed Pharmaceuticals (GLMD) Q2 2025 Earnings

2AprConfirmed

Q2 2024

Q3 2024

Q4 2024

Q2 2025

-1.94

-1.61

-1.27

-0.94

Details

Expected EPS

N/A

Actual EPS

-1.94

Surprise EPS

-1.94

Surprise Percent

+∞%

Description

Galmed Pharmaceuticals (GLMD) has reported earnings of -1.94 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.